The use of serologic markers for collagen synthesis and degradation in systemic sclerosis
- 1 April 1995
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 32 (4) , 584-588
- https://doi.org/10.1016/0190-9622(95)90341-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.Acta Dermato-Venereologica, 1994
- Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism.Acta Dermato-Venereologica, 1993
- Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationClinical Chemistry, 1993
- Treatment of Systemic Sclerosis With Extracorporeal PhotochemotherapyArchives of Dermatology, 1992
- Radioimmunoassay of the carboxyterminal propeptide of human type I procollagenClinical Chemistry, 1990
- Cyclosporin A treatment of systemic sclerosisBritish Journal of Dermatology, 1990
- Serum levels of type III collagen aminopropeptide in patients with systemic sclerodermaArchives of Dermatological Research, 1987
- Type III Collagen Aminopropeptide Levels in Serum of Patients With Progressive Systemic SclerodermaJournal of Investigative Dermatology, 1986
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Dermo-Epidermal Separation with SuctionJournal of Investigative Dermatology, 1967